Nano-silver bactericidal and hemostatic composition
A technology of nano-silver and composition, applied in the field of biomedicine, can solve the problems of inability to rapidly stop bleeding and relieve pain, uneven distribution of metal materials, easy adhesion to clothing, etc., to promote wound healing, simple preparation method, and easy large-scale production effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0079] The third aspect of the present invention provides the preparation method of the nano-silver bactericidal and hemostatic composition, comprising the following steps:
[0080] (1) Add modified hyaluronic acid and ethacridine lactic acid into the reactor in parts by weight, then add water as a solvent, heat to 55°C-75°C to dissolve, stir evenly, and obtain liquid A;
[0081] (2) Processing liquid A in step (1) to obtain substance B;
[0082] (3) Add carboxymethyl chitosan grafted sodium polyacrylate and auxiliary agents to the substance B in step (2) in parts by weight, heat to 60° C. to 80° C., and stir evenly to obtain substance C;
[0083] (4) cooling and filtering the substance C in step (3) to obtain solid D;
[0084] (5) Sterilize the substance D in the step (4) to obtain a nano-silver bactericidal and hemostatic composition.
[0085] In one embodiment, the specific step of post-treatment described in step (2) is: add 0.5mL N-hydroxysuccinimide (0.06mol / L) / 1-( 3-...
Embodiment 1
[0096] Embodiment 1 of the present invention provides a nano-silver bactericidal and hemostatic composition, the preparation raw materials of the nano-silver bactericidal and hemostatic composition are calculated in parts by weight, and include the following components:
[0097] 30 parts of modified hyaluronic acid;
[0098] 3 parts of ethacridine lactate;
[0099] Carboxymethyl chitosan grafted sodium polyacrylate 5 parts;
[0100] Wherein, the modified hyaluronic acid includes organic components and inorganic components; the inorganic components include nano-silver and / or calcium ions;
[0101] The preparation method of described modified hyaluronic acid is:
[0102] (1) Under a nitrogen atmosphere, weigh 0.01mol of hyaluronic acid, 0.25mol of maleic anhydride, 0.3mol of 2,4-hexadienedioic acid and 0.26mol of 1,2,3,4-diepoxybutane for reaction Add 4.5mL of N,N-dimethylformamide and 0.001mol of tetrabutylammonium bromide to the bottle, heat in an oil bath at 90°C for 18h; ob...
Embodiment 2
[0126] Embodiment 2 of the present invention provides a nano-silver bactericidal and hemostatic composition, the preparation raw materials of the nano-silver bactericidal and hemostatic composition are calculated by weight, and include the following components:
[0127] 50 parts of modified hyaluronic acid;
[0128] 5 parts of ethacridine lactate;
[0129] 8 parts of carboxymethyl chitosan grafted sodium polyacrylate;
[0130] Wherein, the modified hyaluronic acid includes organic components and inorganic components; the inorganic components include nano-silver and / or calcium ions;
[0131] The preparation method of the modified hyaluronic acid is the same as in Example 1;
[0132] The ethacridine lactate CAS: 1837-57-6;
[0133] The preparation method of described carboxymethyl chitosan graft sodium polyacrylate is with embodiment 1;
[0134] The bactericidal and hemostatic combination also includes 3 to 8 parts of auxiliary agents, and the auxiliary agents include povido...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com